Papers
2
Total Citations
8
H-Index
2
About
Dr. Sung Chul Kam is a leading urologic surgeon and researcher specializing in the minimally invasive management of benign prostatic hyperplasia (BPH). His work focuses on advancing surgical techniques that alleviate lower urinary tract symptoms while prioritizing the preservation of sexual function and overall quality of life. Dr. Kam’s major contributions include pioneering the combined use of prostatic arterial embolization (PAE) followed by robot-assisted simple prostatectomy (RASP) for patients with large prostates, demonstrating that this staged approach can reduce intraoperative bleeding and improve outcomes. His initial study on this technique has garnered 6 citations, reflecting its clinical relevance. More recently, Dr. Kam has authored a comprehensive narrative review on ejaculatory function preservation during minimally invasive surgical therapies (MISTs) for BPH, a critical topic as treatment goals evolve beyond symptom relief. This work, already cited twice since its 2025 publication, underscores his commitment to patient-centered care. Through his research, Dr. Kam is shaping the future of BPH treatment, balancing efficacy with functional preservation.
Research Focus
Key Achievements
Top Papers
- 1
- 2